Rumors of biggest pharma merger ever drop amid Q2 earnings, contentious FDA adcomms

0:00-23:14

The industry has been abuzz since the weekend when talks of a potential mega-merger between Bristol Myers Squibb and AstraZeneca were reported. Meanwhile, Pfizer, Merck and others release second quarter earnings, with some disclosing pipeline discontinuations and cost-cutting measures. Finally, all eyes turn to the FDA in the wake of heated advisory committee meetings for Capricor Therapeutics and Replimune.

Publisher

BioSpace

Published

August 11, 2026

Duration

23 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

B

BioSpace

@biospace

#biggestpharmamerger #dropamidq2 #contentiousfdaadcomms #lifesciences

The Nile